Colorectal Cancer Treatment in Istanbul: Expert Oncology at Lower Cost

Istanbul has become one of Europe's leading destinations for colorectal cancer treatment, combining JCI-accredited oncology centers with costs 60-75% lower than the UK or USA. Multidisciplinary tumor boards follow ESMO guidelines, and all modern treatments — robotic surgery, FOLFOX chemotherapy, targeted therapy, and immunotherapy — are available.

How much does colorectal cancer treatment cost in Istanbul?

Colorectal cancer surgery costs $8,000–$20,000 in Istanbul versus £20,000–£50,000 in the UK. A full course of FOLFOX chemotherapy (12 cycles) costs $12,000–$20,000 versus £30,000–£60,000. Targeted therapy with bevacizumab costs $2,000–$4,000 per cycle versus £5,000–£10,000 in the UK. The total cost of a complete treatment course for stage III colorectal cancer is typically $25,000–$50,000 in Istanbul versus £70,000–£150,000 in the UK.

Surgical options: laparoscopic and robotic colorectal surgery

Istanbul's colorectal surgeons perform laparoscopic and da Vinci robotic-assisted colectomy and rectal resection. Robotic surgery is particularly valuable for rectal cancer, where the narrow pelvis makes precise dissection critical. Total mesorectal excision (TME) — the gold standard for rectal cancer — is performed at all major Istanbul oncology centers.

Minimally invasive surgery means shorter hospital stays (5-7 days versus 7-10 days for open surgery), less pain, and faster return to normal activity. Most international patients are ready to fly home within 2-3 weeks of surgery.

Molecular testing: the foundation of modern colorectal cancer treatment

Before starting treatment, Istanbul oncologists perform comprehensive molecular testing: RAS mutation testing (KRAS exons 2, 3, 4 and NRAS exons 2, 3, 4), BRAF V600E testing, MSI/MMR testing, and HER2 testing. These results determine which targeted therapies are appropriate and whether immunotherapy is an option.

RAS wild-type tumors are eligible for anti-EGFR therapy (cetuximab, panitumumab). BRAF V600E-mutant tumors are treated with BRAF/MEK inhibitor combinations (encorafenib + binimetinib). MSI-H tumors respond to pembrolizumab immunotherapy.

Chemotherapy protocols: FOLFOX and FOLFIRI

FOLFOX (folinic acid, fluorouracil, oxaliplatin) is the standard adjuvant chemotherapy for stage III colorectal cancer and first-line treatment for metastatic disease. FOLFIRI (folinic acid, fluorouracil, irinotecan) is used as second-line treatment or in patients who cannot tolerate oxaliplatin. Both regimens are administered every 2 weeks as day-case infusions.

FOLFOX costs $1,500–$3,000 per cycle in Istanbul versus £4,000–£8,000 in the UK. Many international patients receive their first 2-4 cycles in Istanbul and continue the remaining cycles with their home oncologist, coordinated by Istanbul's team.

Targeted therapy for colorectal cancer in Istanbul

Istanbul centers offer all major targeted therapy drugs for colorectal cancer: bevacizumab (Avastin) for first and second-line metastatic disease, cetuximab (Erbitux) and panitumumab (Vectibix) for RAS wild-type tumors, ramucirumab (Cyramza) for second-line treatment, and encorafenib + binimetinib for BRAF V600E-mutant tumors.

Immunotherapy for MSI-H colorectal cancer

Approximately 15% of colorectal cancers are microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR). These tumors respond exceptionally well to pembrolizumab (Keytruda), which is now first-line treatment for MSI-H metastatic colorectal cancer. Istanbul centers perform MSI testing on all colorectal cancer biopsies.

Colorectal liver metastases: surgery and ablation

Up to 50% of colorectal cancer patients develop liver metastases. Istanbul's hepatobiliary surgeons perform liver resection for resectable metastases, with 5-year survival rates of 30-50% after complete resection. For unresectable metastases, ablation techniques (radiofrequency ablation, microwave ablation) and conversion chemotherapy are offered.

How to start colorectal cancer treatment in Istanbul

Send your colonoscopy biopsy pathology report, CT scan of chest/abdomen/pelvis, CEA and CA 19-9 tumor markers, and molecular testing results (if available) to our coordination team. Istanbul's multidisciplinary tumor board — colorectal surgeon, medical oncologist, radiation oncologist, and radiologist — will review your case and provide a treatment plan within 48-72 hours.